Literature DB >> 6092931

Selection of cell lines resistant to anti-transferrin receptor antibody: evidence for a mutation in transferrin receptor.

J F Lesley, R J Schulte.   

Abstract

Some anti-murine transferrin receptor monoclonal antibodies block iron uptake in mouse cell lines and inhibit cell growth. We report here the selection and characterization of mutant murine lymphoma cell lines which escape this growth inhibition by anti-transferrin receptor antibody. Growth assays and immunoprecipitation of transferrin receptor in hybrids between independently derived mutants or between mutants and antibody-susceptible parental cell lines indicate that all of the selected lines have a similar genetic alteration that is codominantly expressed in hybrids. Anti-transferrin receptor antibodies and transferrin itself still bind to the mutant lines with saturating levels and Kd values very similar to those of the parental lines. However, reciprocal clearing experiments by immunoprecipitation and reciprocal blocking of binding to the cell surface with two anti-transferrin receptor antibodies indicate that the mutant lines have altered a fraction of their transferrin receptors such that the growth-inhibiting antibody no longer binds, whereas another portion of their transferrin receptors is similar to those of the parental lines and binds both antibodies. These results argue that the antibody-selected mutant cell lines are heterozygous in transferrin receptor expression, probably with a mutation in one of the transferrin receptor structural genes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092931      PMCID: PMC368972          DOI: 10.1128/mcb.4.9.1675-1681.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Isolation and characterization of an alpha-amanitin-resistant rat myoblast mutant cell line possessing alpha-amanitin-resistant RNA polymerase II.

Authors:  D G Somers; M L Pearson; C J Ingles
Journal:  J Biol Chem       Date:  1975-07-10       Impact factor: 5.157

Review 2.  On the nature of hereditable variation in cultured somatic cells.

Authors:  L Siminovitch
Journal:  Cell       Date:  1976-01       Impact factor: 41.582

3.  Retention of lymphocyte characteristics by myelomas and theta + -lymphomas: sensitivity to cortisol and phytohemagglutinin.

Authors:  P Ralph
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

4.  Mutations affecting adenine phosphoribosyl transferase activity in Chinese hamster cells.

Authors:  L A Chasin
Journal:  Cell       Date:  1974-05       Impact factor: 41.582

5.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

6.  Mutants of cultured chinese hamster cells deficient in adenine phosphoribosyl transferase.

Authors:  G E Jones; P A Sargent
Journal:  Cell       Date:  1974-05       Impact factor: 41.582

7.  Identification of transferrin as a lymphocyte growth promoter in human serum.

Authors:  D C Tormey; R C Imrie; G C Mueller
Journal:  Exp Cell Res       Date:  1972-09       Impact factor: 3.905

8.  A mutational assay system using the thymidine kinase locus in mouse lymphoma cells.

Authors:  D Clive; W G Flamm; M R Machesko; N J Bernheim
Journal:  Mutat Res       Date:  1972-09       Impact factor: 2.433

9.  Biological effects of transferrin on human lymphocytes in vitro.

Authors:  D C Tormey; G C Mueller
Journal:  Exp Cell Res       Date:  1972-09       Impact factor: 3.905

10.  Stimulation of DNA synthesis in cultures of mouse spleen cell suspensions by bovine transferrin.

Authors:  A Vogt; R I Mishell; R W Dutton
Journal:  Exp Cell Res       Date:  1969-02       Impact factor: 3.905

View more
  10 in total

1.  Inhibition of cell growth by monoclonal anti-transferrin receptor antibodies.

Authors:  J F Lesley; R J Schulte
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

2.  Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.

Authors:  Patrick P Ng; Gustavo Helguera; Tracy R Daniels; Simon Z Lomas; Jose A Rodriguez; Gary Schiller; Benjamin Bonavida; Sherie L Morrison; Manuel L Penichet
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

3.  Selection and characterization of transferrin receptor mutants using receptor-specific antibodies.

Authors:  J Lesley; R Schulte
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide.

Authors:  David Schubert; Thomas Soucek; Barbara Blouw
Journal:  Eur J Neurosci       Date:  2009-03-23       Impact factor: 3.386

5.  Identification and characterization of the human Pgp-1 glycoprotein.

Authors:  C M Isacke; C A Sauvage; R Hyman; J Lesley; R Schulte; I S Trowbridge
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

6.  Intermolecular disulfide bonds are not required for the expression of the dimeric state and functional activity of the transferrin receptor.

Authors:  E Alvarez; N Gironès; R J Davis
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

7.  Transferrin receptors recycle to cis and middle as well as trans Golgi cisternae in Ig-secreting myeloma cells.

Authors:  J W Woods; M Doriaux; M G Farquhar
Journal:  J Cell Biol       Date:  1986-07       Impact factor: 10.539

Review 8.  Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents.

Authors:  Pierre V Candelaria; Lai Sum Leoh; Manuel L Penichet; Tracy R Daniels-Wells
Journal:  Front Immunol       Date:  2021-03-17       Impact factor: 7.561

9.  Identification of the intermolecular disulfide bonds of the human transferrin receptor and its lipid-attachment site.

Authors:  S Q Jing; I S Trowbridge
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

10.  Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.

Authors:  J Lesley; N English; A Perschl; J Gregoroff; R Hyman
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.